Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PARD

Poniard Pharmaceuticals, Inc. (MM) (PARD)

Poniard Pharmaceuticals, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PARD
DateTimeSourceHeadlineSymbolCompany
04/01/201200:00MarketwiredPoniard Pharmaceuticals Common Stock to Be Delisted From Nasdaq Stock Market, Intention to List on OTC Bulletin BoardNASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
24/12/201107:37Edgar (US Regulatory)Current report filing (8-K)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
23/11/201106:13Edgar (US Regulatory)Current report filing (8-K)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
22/11/201105:15MarketwiredPoniard Pharmaceuticals Announces Shareholders Approve Merger With ALLOZYNENASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
22/11/201101:00MarketwiredSteps in the Right Direction - Featured Research on Poniard Pharmaceuticals, Inc. and Gilead Sciences, Inc.NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
19/11/201105:00Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
19/11/201100:30MarketwiredPoniard Pharmaceuticals Announces Licensing Agreement for Focal Adhesion Kinase TechnologyNASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
11/11/201106:54Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
10/11/201105:16Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
10/11/201100:30MarketwiredISS Proxy Advisory Services Recommends Poniard Shareholders Vote "FOR" Poniard's Proposed Merger With ALLOZYNE and Reverse St...NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
08/11/201122:05Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
08/11/201100:30MarketwiredGlass Lewis Recommends Poniard Shareholders Vote "FOR" Poniard's Proposed Merger With ALLOZYNE and Reverse Stock SplitNASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
04/11/201121:10Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
03/11/201107:01Edgar (US Regulatory)Current report filing (8-K)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
29/10/201107:16Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
29/10/201107:01MarketwiredPoniard Pharmaceuticals Reports Third Quarter 2011 Financial ResultsNASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
29/10/201104:59Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
29/10/201102:19Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
28/10/201123:30MarketwiredEgan-Jones Recommends Poniard Shareholders Vote "FOR" Poniard's Proposed Merger With ALLOZYNE and Reverse Stock SplitNASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
25/10/201106:47Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
22/10/201105:00Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
13/10/201104:43Edgar (US Regulatory)Current report filing (8-K)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
13/10/201104:41Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
13/10/201104:37Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
12/10/201100:10Dow Jones NewsRegistration Effectiveness Orders Issued By The SECNASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
11/10/201121:00Edgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
08/10/201108:43MarketwiredPoniard Pharmaceuticals Announces Effectiveness of Form S-4 Registration Statement for the Proposed Merger with ALLOZYNENASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
08/10/201108:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
08/10/201108:26Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
08/10/201104:22Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:PARD